COL-PROBENECID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Col-probenecid, and when can generic versions of Col-probenecid launch?
Col-probenecid is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in COL-PROBENECID is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
Summary for COL-PROBENECID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 67 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | COL-PROBENECID at DailyMed |
Recent Clinical Trials for COL-PROBENECID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| United States Department of Defense | Phase 3 |
| University of Miami | Phase 3 |
| Haisco Pharmaceutical Group Co., Ltd. | Phase 1 |
Pharmacology for COL-PROBENECID
| Drug Class | Alkaloid |
Anatomical Therapeutic Chemical (ATC) Classes for COL-PROBENECID
US Patents and Regulatory Information for COL-PROBENECID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | COL-PROBENECID | colchicine; probenecid | TABLET;ORAL | 084279-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
